Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
- Details
- Category: Sanofi
![Sanofi-aventis Sanofi-aventis](/images/stories/logo/sanofi-aventis.gif)
Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year
- Details
- Category: Abbott
![Abbott Abbott](/images/stories/logo/abbott.gif)
Bayer raises its brand profile
- Details
- Category: Bayer
![Bayer Bayer](/images/stories/logo/bayer.gif)
KOMBIGLYZE™ XR tablets approved in the US
- Details
- Category: AstraZeneca
![AstraZeneca AstraZeneca](/images/stories/logo/astrazeneca.gif)
Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership
- Details
- Category: Amgen
![Amgen Inc. Amgen Inc.](/images/stories/logo/amgen.gif)
Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards
- Details
- Category: Amgen
![Amgen Amgen](/images/stories/logo/amgen.gif)
New data show potential for Novartis Meningitis B vaccine (4CMenB) candidate
- Details
- Category: Novartis
![Novartis Novartis](/images/stories/logo/novartis_b.gif)
More Pharma News ...
- Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
- Lilly CEO Calls for a 'Wave of Invention' to Reduce the Toll of Diabetes
- Pfizer Reports Third-Quarter 2010 Revenues of $16.2 Billion
- Simcere and Bristol-Myers Squibb Enter Innovative Partnership to Develop Early-Stage Oncology Compound
- Lundbeck expects to deliver solid profits during a period of new product launches and patent expiries
- Phase III ROCKET AF Study of Rivaroxaban meets its primary efficacy endpoint with Comparable Safety vs. Warfarin
- Nycomed to accelerate expansion in China